Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,269 Jan 1 – Oct 6, 2026
- Disclosed funding
- $193.2B 1935 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| K K25.aiCompany profile Develops a livestreaming platform with interactive prediction markets for sports and entertainment. Develops a livestreaming platform with interactive prediction markets for sports and entertainment. | Undisclosed | Series A | AI, Fintech | Singapore | Investors | |
| P PaperCompany profile Design platform for the agentic era, enabling designers and engineers to collaborate through a shared language. Design platform for the agentic era, enabling designers and engineers to collaborate through a shared language. | $34M | Series A | AI | United States | Investors | |
| k kausableCompany profile Developing reasoning-first frontier AI that adapts to changing context without retraining Developing reasoning-first frontier AI that adapts to changing context without retraining | €12M | Seed | AI | Germany | Investors | |
| R Ropedia builds data infrastructure for physical AI. | $30M | Pre-Series AUndisclosed | AI, Robotics | Singapore | Investors Undisclosed | |
| t AI startup automating customer-facing operations with AI agents | $15M | Seed | AI | Germany | Investors | |
| A AbstractCompany profile Streaming security operations that detect threats in motion and route data across an organisation’s tools. Streaming security operations that detect threats in motion and route data across an organisation’s tools. | $25M | Undisclosed | AI, Cybersecurity | United States | Investors | |
| CH Automates the financial infrastructure of American healthcare | $120M | Series DSeries C+ | AI, Healthtech | United States | Investors | |
| TB Transcripta BioCompany profile AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases | $24M | Series A | AI, Biotech | United States | Investors | |
| A ArrakisCompany profile AI software company helping industrial organisations deploy AI agents into mission-critical operational workflows AI software company helping industrial organisations deploy AI agents into mission-critical operational workflows | $30M | Series A | AI, Industrial tech | United Kingdom | Investors | |
| HE Health EndeavorsCompany profile Health Endeavors provides AI-driven care management tools for accountable care organizations Health Endeavors provides AI-driven care management tools for accountable care organizations | Undisclosed | Growth | AI, Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Halluminate, ByteAsk, Firecrawl
104rounds2led - 2General Catalyst
Melius, General Intuition, Sol
74rounds5led - 3Andreessen Horowitz (a16z)
Ghost, Conway Research, EliseAI
72rounds11led - 4Lightspeed
RobCo, Enveda, Snorkel AI
63rounds4led - 5Accel
Arivihan, Ando, Ema
50rounds4led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.